Loxiglumide 5 mg | Purity Not Available
TargetMol
Loxiglumide
Search Results
BIIB021 25 mg | 98.38%
TargetMol
BIIB021 is an orally-available, fully synthetic inhibitor of HSP90(Ki=1.7 nM, EC50=38 nM).
More Information Supplier PageBIIB021
Itanapraced 25 mg | 98.00%
TargetMol
Itanapraced (CHF5074), a γ-secretase modulator, reduces Aβ42/40 secretion (IC50: 3.6/18.4 μM).
More Information Supplier PageItanapraced
Itanapraced 1 mg | 98.00%
TargetMol
Itanapraced (CHF5074), a γ-secretase modulator, reduces Aβ42/40 secretion (IC50: 3.6/18.4 μM).
More Information Supplier PageItanapraced
NVP-TAE 684 100 mg | Purity Not Available
TargetMol
NVP-TAE 684 is a excellently effective and specific ALK inhibitor(IC50=3 nM).
More Information Supplier PageNVP-TAE 684
NVP-TAE 684 25 mg | Purity Not Available
TargetMol
NVP-TAE 684 is a excellently effective and specific ALK inhibitor(IC50=3 nM).
More Information Supplier PageNVP-TAE 684
NVP-TAE 684 2 mg | Purity Not Available
TargetMol
NVP-TAE 684 is a excellently effective and specific ALK inhibitor(IC50=3 nM).
More Information Supplier PageNVP-TAE 684
Loxiglumide 25 mg | Purity Not Available
TargetMol
Loxiglumide
Loxiglumide 100 mg | Purity Not Available
TargetMol
Loxiglumide
PHT-427 100 mg | Purity Not Available
TargetMol
PHT-427 (CS-0223) is a dual Akt (Ki: 2.7 μM) and PDPK1 (Ki: 5.2 μM) inhibitor (high-affinity binding for the PH domains of Akt and PDPK1).
More Information Supplier PagePHT-427
